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We hypothesised that Hansen Solubility Parameters (HSPs) can be used to predict drug–nail affinities.
Our aims were to: (i) determine the HSPs (dD, dP, dH) of the nail plate, the hoof membrane (a model for
the nail plate), and of the drugs terbinafine HCl, amorolfine HCl, ciclopirox olamine and efinaconazole,
by measuring their swelling/solubility in organic liquids, (ii) predict nail–drug interactions by compar-
ing drug and nail HSPs, and (iii) evaluate the accuracy of these predictions using literature reports of
experimentally-determined affinities of these drugs for keratin, the main constituent of the nail plate
and hoof. Many solvents caused no change in the mass of nail plates, a few solvents deswelled the nail,
while others swelled the nail to varying extents. Fingernail and toenail HSPs were almost the same,
while hoof HSPs were similar, except for a slightly lower dP. High nail–terbinafine HCl, nail–amorolfine
HCl and nail–ciclopirox olamine affinities, and low nail–efinaconazole affinities were then predicted,
and found to accurately match experimental reports of these drugs’ affinities to keratin. We therefore
propose that drug and nail Hansen Solubility Parameters may be used to predict drug–nail interactions,
and that these results can assist in the design of drugs for the treatment of nail diseases, such as ony-
chomycosis and psoriasis. To our knowledge, this is the first report of the application of HSPs in ungual
research.
 2016 The Authors. Published by Elsevier B.V. This is anopenaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
The human nail can suffer from a number of diseases, such as
onychomycosis (fungal infections of the nail) and psoriasis [1].
These diseases are common and significantly affect the sufferers’
quality of life; however, their current treatment is far from ideal,
with long treatment durations and low success rates, even for
the newest medicines [2–9]. For effective treatment, drugs must
permeate into the nail (their site of action) following topical and/
or oral administrations. Ungual (i.e. of the nail) drug permeation
depends on the properties of the drug (such as its size, charge),
the formulation (such as its pH, which influences drug charge),
the nail plate (such as its porosity and hydration), as well as
drug–nail, drug-formulation and formulation-nail interactions,
such as drug-keratin binding, drug release from the formulation
and the latter’s adhesion to and residence on the nail plate. The
influence of these factors on ungual permeability has been
researched to varying extents, and the need for a more rational
approach to the development of new therapies is obvious [10].While the relationship between certain factors and ungual perme-
ation is well-established (for example that of drug size) [11,12], the
influence of other parameters such as nail–drug interactions, has
been much less investigated.
Drug binding to keratin – the main constituent of the human
nail plate – is known to reduce its antifungal effect, as shown by
Tatsumi et al. (2002) who reported a direct relationship between
a drug’s affinity to keratin and the extent of reduction in its anti-
fungal activity in the presence of keratin [13]. Drug binding to nail
keratin is also expected to influence ungual drug permeation. For
example, in evaluations of topical drug carriers in Franz cell type
setups, a high affinity for nail keratin is expected to lead to greater
drug partitioning out of the carrier into the nail plate. Concur-
rently, a high drug–nail affinity will reduce the drug partitioning
out of the nail into the receptor medium, resulting in lower drug
flux and calculated ungual permeability. This may help explain
the lower flux, but greater drug-in-nail levels of terbinafine (which
has higher keratin affinity than amorolfine [13]) when UV-cured
gels loaded with terbinafine or amorolfine were evaluated as topi-
cal nail medicines [14]. Sugiura et al. (2014) also suggested that the
greater ungual permeability of efinaconazole, compared to amorol-
fine and ciclopirox, was related to its lower keratin affinity [15].
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effective drug design and the success of therapy. With this in mind,
the aims of the research discussed in this paper were to:
(i) Determine the Hansen Solubility Parameters (HSP) of the
nail plate, the hoof membrane (a commonly used model
for the nail plate in ungual research due to the scarcity
and expense of nail plates), and of the anti-onychomycotic
drugs terbinafine HCl, amorolfine HCl, ciclopirox olamine
and efinaconazole.
(ii) Predict nail–drug interactions based on the determined
HSPs, and evaluate whether these predictions reflect litera-
ture reports of experimentally-determined affinities of these
drugs for keratin.
Solubility parameters – first developed by Hildebrand and co-
workers [16], and which help to quantify the statements ‘like dis-
solves like’ or ‘like seeks like’ [16–18], have been widely used to
predict materials’ compatibilities, including in pharmaceutical
drug development [19–22]. Hansen Solubility Parameters divide
the total solubility parameter (dT) into individual parts arising from
dispersion forces (dD), permanent dipole–permanent dipole forces
(dP), and hydrogen bonding (dH) [17] such that:
d2T ¼ d2D þ d2P þ d2H ð1Þ
The HSP parameters of materials can be found experimentally,
based on the observation of interaction (or its absence) between
the test material and solvents with well-defined HSPs. The solvents
are then divided into those which interact strongly with the test
material (‘good’ solvents), and those which do not interact (‘bad’
solvents). The dD, dP, dH HSPs of all the solvents are then plotted
3-dimensionally, and a computer program locates the ‘sphere’ in
HSP space that includes the ‘good’ solvents and excludes the
‘bad’ solvents, with a minimum of error. The centre coordinates
of the sphere give the HSPs (dD, dP, dH) of the test material, while
the radius of the sphere (Ro) describes how large/small the interac-
tion range is.
To compare two materials, Ra (the solubility parameter ‘dis-
tance’) between them can be calculated by
ðRaÞ2 ¼ 4ðdD2  dD1Þ2 þ ðdP2  dP1Þ2 þ ðdH2  dH1Þ2 ð2Þ
where the subscripts 1 and 2 refer to material 1 and material 2.
For high affinity between two materials, Ra must be less than
the Ro of the test material, and a Relative Energy Difference
(RED) value is often used to quantify distances Ra relative to Ro
as follows:
RED ¼ Ra
Ro
ð3Þ
Thus RED < 1 indicates high affinity, while RED > 1 indicates low
affinity.
In applying this approach to the nail, knowledge of the nail
plate’s HSPs and use of drug–nail RED values is expected to assist
the design and/or selection of drugs which have the desired (high
or low) affinity for the nail plate. A high drug–nail affinity may
mean that an antifungal agent’s potency is diminished, but it also
means that the drug will concentrate in the nail, resulting in a drug
depot in the nail which can enable less frequent drug dosing, as
evidenced by oral itraconazole pulse therapy in the treatment of
onychomycosis. The nail plate’s HSPs will also be useful in other
industries, such as the nail cosmetic industry, where various chem-
icals are used, and where chemical-nail interactions are important
for the cosmetic’s properties such as wear. Knowledge of the hoof
membrane’s HSPs should help us further evaluate this material’s
suitability as a model for the nail plate in ungual research.2. Materials and methods
2.1. Materials
Healthy nail clippings were collected from adult female and
male volunteers, aged 15–45 years (ethics approval, REC/B/10/01
School of Pharmacy, University of London, UK). Bovine hoof mem-
branes were obtained from Madras Veterinary College Teaching
Hospital (Chennai, India). Amorolfine hydrochloride was obtained
from Ranbaxy Research Laboratories (Gurgaon, Haryana, India).
Terbinafine hydrochloride was obtained from AK Scientific (Union
City, CA, USA). Ciclopirox olamine was obtained from Zhejiang
Huadee Chemicals Co. (Taizhou, Zhejiang, China).
Butyl benzoate, decane, dibutyl phthalate, 1,5-dichloropentane,
dimethyl phthalate, 2-ethyl hexanol, glycerol triacetate, 1-hexene,
octane, 1-octanol, triethyl citrate, 1,2-propanediol, butanol,
1-methyl-2-pyrrolidone, 1-octanol, 1-pentanol, 1-vinyl-2-
pyrrolidone, 2,2,4-trimethylpentane, acetone, acetic anhydride,
butyl acetate, diethylamine, ethanolamine, diethanolamine,
dimethyl formamide, dimethyl sulfoxide, ethylene glycol, for-
mamide, isopropyl myristate, isopropyl palmitate, piperidine, pyr-
idine, diethyl ether, dibutyl phthalate, benzyl butyl phthalate,
acetophenone, propylene carbonate, methyl acetate, ethyl acetate,
diacetone alcohol, dodecanol, methyl formate, 2-chloroethanol,
hexanol, pyrrole, acetaldehyde, 4-chloro-1-butanol, 3-chloro-1-
propanol, ethylenediamine, amino-2-propanol, 2-methylamino
propanol, 1-methoxy-2-propanol, were obtained from Sigma
Aldrich (UK). Acetone, acetonitrile, benzaldehyde, formaldehyde,
hexane, methanol, and triethylamine were obtained from Fisher
Scientific (Loughborough, UK). Lactic acid was obtained from
Fisons Scientific Equipment (London, UK). Heptane was obtained
from BDH Chemicals Ltd (UK). Glycerol was obtained from Alfa
Aesar (Heysham, UK).2.2. Methods
2.2.1. Determination of nail and hoof HSPs
Sample preparation: Fingernail and toenail clippings were
washed with distilled water and any debris was carefully removed
using a spatula without damaging the nail plate. The nail plates
were then allowed to dry and equilibrate at room temperature
for at least 60 min. The relative humidity in the laboratory was
on average about 44%, where, the nail water content is expected
to be about 8% w/w (from relative humidity – nail water content
profiles reported in [23–26]). While it is possible that the nail’s
water content could affect the extent of swelling by organic liquids,
we opted to air-dry (as opposed to oven-dry) the nails, as the data
obtained in this study are more likely to reflect real-life situation
(where nails are hydrated to some extent). Slices of bovine hoof
membranes were cut from larger pieces using a scalpel, following
overnight soaking in water to soften the tissue. The hoof slices
were cut into a thickness of approximately 0.40 mm to reflect that
of human nail clippings; following measurement of twenty finger-
and toe-nail clippings from different donors using a digital
micrometre, the average thicknesses were found to be 0.34 mm
and 0.5 mm for finger- and toe-nail clippings respectively.
Nail and hoof HSPs were determined by measuring their swel-
ling behaviour in a selection of solvents, of varying and well-
defined HSP values. Fingernail and toenail clippings and hoof slices
were weighed, then placed individually in glass vials, after which
three mL of a solvent was added, and the vials were placed in a
water bath at 25 C. The mass of the nail clipping/hoof was moni-
tored at regular intervals for a total of 35 days, by removing the
sample, wiping off the excess liquid and weighing the sample
before returning to the vial. The experiments were carried out in
Table 2
HSPs of fingernail, toenail and hoof pieces.
Sample HSPs (MPa½) Ro
dD dP dH Total (dT)
Fingernail 17.7 ± 0.5 20.9 ± 0.3 18.6 ± 0.6 27.4 ± 0.2 12.7 ± 0.4
Toenail 15.9 ± 0.3 19.6 ± 0.7 19.3 ± 0.4 25.3 ± 0.6 11.5 ± 0.6
Hoof 16.5 ± 0.5 15.5 ± 1.2 19.3 ± 1.4 23.5 ± 2.1 10.5 ± 2.3
34 B. Hossin et al. / European Journal of Pharmaceutics and Biopharmaceutics 102 (2016) 32–40triplicate. The mean extent of nail swelling for each solvent was
then inputted into the HSPiP software (3rd edition 3.1.12). The
software plots the dD, dP and dH of each organic liquid along the
three axes of a three-dimensional graph, after which, the program
calculates a sphere whose centre coordinates give the dD, dP and dH
of the nail/hoof. Multiple calculations allowed the obtainment of
mean and standard deviation values. Only solvents which did not
damage the nail plate and hoof were used for the HSP calculation,
i.e. phosphoric acid, lactic acid, ethanolamine and ethylene dia-
mine were excluded. Water was also excluded from the HSP calcu-
lation, due to its exceptional behaviour as a solvent, and as per
[27]. Due to the small influence of solvent molar volume on nail
swelling, HSPs were also calculated using only solvents with molar
volumes between 50 and 100 cm3/mol. This did not influence the
HSP values or the fit greatly (data not shown), and therefore the
values shown in Table 2 are those using solvents with molar vol-
umes 37–330 cm3/mol. HSPs were also calculated using double
spheres in the HSPiP software. This did not result in any improve-
ment of the fit, and the HSPs reported in this paper are therefore
those using single spheres.
2.2.2. Determination of antifungal drug HSPs
The solubilities of terbinafine hydrochloride, amorolfine
hydrochloride, and ciclopirox olamine in a number of solvents with
a wide range of HSPs were investigated. The number of solvents
used (between 33 and 39 for each drug) depended on the number
needed to optimise the HSP sphere fit to be as close as possible to 1,
and fits of 0.9–1.0 were obtained. Rough saturation solubility test-
ing was carried out whereby 10 mg of each drug was added to one
mL of each solvent, and the mixtures were left stirring overnight in
a water bath at 25 C, followed by visual inspection to determine
whether the drug had fully dissolved. If the drug had fully dis-
solved, another 10 mg of drug was added, the mixture stirred over-
night and inspected. The process was repeated until drug
precipitation was seen or until a total of 100 mg of drug had been
added. Finally, the solutions were left in the water bath at 25 C forTable 1
% Mass change of finger nails, toe nails and hoof membranes, following a 35-day
incubation in liquids, n = 3.
Liquid Fingernail Toenail Hoof
Phosphoric acid 155.0 ± 18.8 120.0 ± 16 Destroyed
Ethanolamine 142.2 ± 14.5 93.4 ± 3.3 Destroyed
Ethylene diamine 145.0 ± 4.0 154.0 ± 12 Destroyed
Lactic acid 88.4 ± 2.6 75.8 ± 6.0 186 ± 20
Water 55.0 ± 0.8 43.3 ± 4.1 61.2 ± 0.4
Formamide 53.3 ± 2.9 56.7 ± 2.5 88.3 ± 14.4
DMSO 52.3 ± 7.9 48.3 ± 9.2 93.1 ± 17.5
2-Chloroethanol 48.4 ± 7.3 53.2 ± 11.8 76.3 ± 4.3
Ethylene glycol 37.2 ± 6.4 31.0 ± 5.3 73.0 ± 13
Formaldehyde 26.8 ± 7.4 31 ± 2.5 43.0 ± 1.1
2-Methoxy ethanol 16.4 ± 0.6 13.9 ± 10.4 30.5 ± 2.8
Amino-2-propanol 14.7 ± 4.6 14.0 ± 1.8 29.7 ± 2.8
2-Methyl amino propanol 12.8 ± 2.1 15 ± 10.7 25.3 ± 1.2
DMF 11.2 ± 3.5 18.4 ± 2.1 34.3 ± 8.8
Methanol 11.2 ± 3.5 8.1 ± 4.5 29.7 ± 22.2
Dichloromethane 8.7 ± 1.6 12.4 ± 2.9 12.7 ± 5.1
p-Xylene 8.4 ± 2.1 12.2 ± 5.1 3.2 ± 4.8
Dichloroethane 6.2 ± 2.2 6.2 ± 8.4 11.0 ± 2
NMP 5.6 ± 2.1 8.5 ± 6.0 4.2 ± 1.4
Ethanol 2.9 ± 1.7 4.0 ± 1.2 7.2 ± 2.0
Diacetone alcohol 11.2 ± 0.8 9.73 ± 1 11.2 ± 5.5
Vinyl pyrrolidone 10.9 ± 0.8 8.9 ± 0.7 0
Benzyl alcohol 7 ± 0.8 5.3 ± 0.8 0
Pentanol 5.5 ± 3.1 4.1 ± 1.3 1.5 ± 3.4
Acetone 5 ± 0.4 5.12 ± 0.7 0
Toluene 8.3 ± 2.1 0 4.7 ± 4.6
Octanol 0 0 11.7 ± 1.5
Butanol 0 0 1.5 ± 0.972 h to ensure that no change in drug solubility occurred. Each sol-
vent was then given either a score of 1 if 10 mg or more of the drug
dissolved, or a score of zero if 10 mg did not dissolve. The solubility
scores were then inputted into the HSPiP software, which calcu-
lated the drugs’ HSPs.
Two additional solubility scoring methods were used to deter-
mine the HSPs of ciclopirox olamine, in order to determine which
method would give an optimal solubility sphere and fit. The first
was assignment of scores of 1–6 to each solvent as follows: scores
of 1, 2, 3, 4, 5 and 6 for drug dissolution of: P80 mg, <80 and
P50 mg, <50 and P40 mg, <40 and P20 mg, <20 and P10 mg,
<10 mg respectively. The second was the assignment of a score
according to the total amount of drug dissolved in each solvent.
For instance, if 50 mg of ciclopirox was dissolved in a solvent, then
the score would be 50 for that solvent. These two additional scor-
ing methods were not as practical and did not improve data fits
compared to the first method mentioned in the paragraph above,
and were therefore not explored further.
The HSP of efinaconazole was obtained from the HSPiP soft-
ware, due to the high cost of the amount of efinaconazole needed
for solubility studies and the fact that efinaconazole’s HSP can be
calculated (unlike those of the drug salts). The dT, dD, dP, and dH val-
ues were calculated from the molecular formula, using the Y-MB
method. The latter was developed by fitting thousands of com-
pounds using Neural Network techniques and enables the estima-
tion of a chemical’s properties (HSPiP software eBook).
2.2.3. Validation of the measured HSPs
The experimentally determined HSP values should enable qual-
itative predictions of nail/hoof swelling and of drug solubility in
any untested liquid if the latter’s HSPs are known. In order to
determine whether this holds true, nail/hoof swelling and drug sol-
ubility in a number of solvents – which had not been used in the
HSP determination – were theoretically predicted, and the accu-
racy of the predictions was then experimentally tested as
described in Sections 2.2.1 and 2.2.2. Theoretical predictions were
based on RED values as explained in the Introduction, with a RED
value of less than one predicting nail/hoof swelling or drug disso-
lution in a liquid at a concentration of 10 mg/mL.
The liquids used for the validation of nail/hoof swelling are
shown in Table 4, and had molar volumes under 100 m3/mol to
avoid any possible effects of molecular size on swelling. Of these,
five were predicted to swell nail, and four were predicted to cause
no swelling. The liquids used for the validation of drug solubility
are shown in Table 5; approximately half of the drug-liquid combi-
nations were predicted to show drug solubility. HSPs of all the liq-
uids were obtained from the HSPiP software.Table 3
HSPs of amorolfine HCl, terbinafine HCl, ciclopirox olamine, and efinaconazole.
Drug HSPs (MPa½)
dD dP dH dT
Amorolfine HCl 18.1 ± 0.4 12.2 ± 0.5 16.9 ± 0.3 22.6 ± 0.4
Terbinafine HCl 17.1 ± 0.7 16.6 ± 1.1 13.9 ± 0.6 23.8 ± 1.4
Ciclopirox olamine 17.4 ± 0.6 13.9 ± 0.6 17.2 ± 0.6 28.1 ± 0.3
Efinaconazole 19.1 6 5.6 20.8
Table 4
Predicted and experimentally-determined nail and hoof swelling in liquids.
RED between liquid and nail/hoof Nail/hoof swells?
Liquid Fingernail Toenail Hoof Predicted Experimental
N-methyl formamide 0.7 0.7 0.4 Yes Yes
Methyl Iodide 1.5 1.2 0.9 Nails no; hoof yes Yes
Ethylene cyanohydrin 0.8 0.7 0.5 Yes Yes
Glycerol formal 0.6 0.6 0.7 Yes No
1,4-Butanediol 1.0 1.1 1.0 No No
Pyrrole 0.7 0.8 0.7 Yes Yes
Allyl alcohol 0.7 0.6 0.5 Yes Yes
Carbon disulphide 2.2 1.2 1.8 No No
Biuret 1.0 1.4 1.1 No No
Bold text shows disagreement between predicted and experimental swelling.
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comparisons with literature values of experimentally-determined
drug-keratin affinities
Nail–drug RED values for terbinafine HCl, amorolfine HCl, ciclo-
pirox olamine and efinaconazole were calculated using the follow-
ing equation:
RED ¼ Ra
Ro
ð4Þ
where Ra is the solubility parameter ‘distance’ between the nail and
the drug, and was calculated using Eq. (2) (shown in the Introduc-
tion) and Ro is the radius of the nail’s HSP sphere. RED values below
1 were taken as indications of high nail–drug affinities. Conversely,
RED values above 1 were taken as indications of low nail–drug
affinities. The predicted nail–drug affinities were then compared
with experimentally-obtained values of drug-keratin affinities,
which were obtained from Sugiura et al. [15] and Tatsumi et al. [13].-15
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Fig. 1. %Mass change of fingernail clippings incubated in organic liquids over time. Mean
are not shown to ease visualisation.3. Results and discussion
With a few exceptions, the liquids which swelled or deswelled
(i.e. caused an increase or decrease in nail/hoof mass) the finger-
nails, also swelled toenails and hoof pieces, and those which
caused no change in the mass of fingernails also caused no change
in the mass of toenails and hoof pieces (Table 1).
3.1. Swelling behaviour of nail and hoof in a range of organic liquids
3.1.1. No nail swelling
A large number of liquids – more than half of those tested –
caused no change in the mass of fingernail, toenail and hoof, that
is, showed limited affinity for, and uptake into the nail/hoof. These
liquids include acetic anhydride, acetonitrile, acetophenone, ben-
zaldehyde, benzyl butyl phthalate, 4-chloro-butanol, chloroben-
zene, chloroform, 3-chloropropanol, cyclohexane, cyclohexanol,5 30 35
DMSO
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Formamide
2-Chloroethanol
Ethylene glycol
Formaldehyde
2-Methoxy ethanol
Amino-2-propanol
2-Methyl amino propanol
DMF
DCM
Xylene
NMP
Methanol
Dichloroethane
Ethanol
Acetone
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Benzyl alcohol
Toluene
Vinyl pyrrolidone
Diacetone alcohol
of n = 3 is shown. Solvents which caused no change in mass and standard deviations
36 B. Hossin et al. / European Journal of Pharmaceutics and Biopharmaceutics 102 (2016) 32–40dibutyl phthalate, 1,3-dioxolane, dodecanol, ethyl acetate, glycerol,
glycerol triacetate, hexane, 1-hexanol, isopropyl palmitate, 1-
methoxy-2-propanol, piperidine, propylene carbonate, propylene
glycol, and THF. The lack of nail swelling is likely due to the fact
that the nail plate has a highly ordered, thus stable, structure in
its component proteins and lipids. The nail plate consists mainly
of keratin, followed by water (at 8–22% depending on ambient
humidity), lipids (which make up less than 5% of the nail plate
mass) and small amounts of elements such as calcium, magnesium,
sodium, potassium, iron, copper, zinc, aluminium, and chlorine
[28–30]. The nail plate proteins are known to be predominantly
in the a-helix conformation, heavily folded and linked by multiple
disulphide bonds which are also in a stable conformation, while
the lipids are in a highly-ordered crystal state and much of the nail
plate water content is bound to keratin [31,32].3.1.2. Nail swelling
Liquids which swell/deswell the nail/hoof are shown in Table 1,
and the swelling/deswelling profiles are shown in Figs. 1–3. The
extents of fingernail and toenail swelling in a particular liquid at
day 35 were statistically the same (ANOVA and post hoc Tukey;
p > 0.05, Table 1), although swelling occurred at a faster rate in fin-
gernails, possibly due to their thinner structure. Hoof pieces
swelled to greater extents compared to fingernails and toenails
(ANOVA and post hoc Tukey; p 6 0.05, Table 1), correlating with
literature reports of its greater swelling in water [33] and its
greater permeability [12].-15.00
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Fig. 2. % Mass change of toenail clippings incubated in organic liquids over time. Mean o
are not shown to ease visualisation.The extent of nail/hoof swelling was significantly different for
the different liquids (Table 1). One way ANOVA and post hoc Tukey
on the extent of swelling at day 35 showed that, for both finger-
nails and toenails, solvents which swelled (but did not destroy)
the nail plates can be grouped in descending order of % swelling
as follows: (i) water, formamide, DMSO and 2-chloroethanol, (ii)
ethylene glycol and formaldehyde, and (iii) ethanol, methanol, 2-
amino-propanol, DCM, dichloroethane, 2-methoxy ethanol, 2-
methyl amino propanol, NMP, xylene and DMF. The groups differed
significantly (p 6 0.05) from one another in terms of extent of nail
swelling, while no statistically significant difference was obtained
among solvents within one group (pP 0.05). Similarly, solvents
which swelled the hoof slices could also be grouped in descending
order of % swelling as follows: (i) DMSO and formamide, (ii)
formaldehyde and ethylene glycol, and (iii) ethanol, methanol,
xylene, dichloroethane, DCM, NMP, 2-methoxy ethanol, 2-methyl
amino propanol and DMF (one way ANOVA and post hoc Tukey,
p 6 0.05). Thus, it can be seen that bovine hoof and human nail
plate have affinities to the same solvents, further confirming the
suitability of hoof as a model for the nail.
When the properties of the organic liquids are examined for
their influence on the extent of nail/hoof swelling, a small, but sig-
nificant correlation (Pearson correlation, p < 0.05) between solvent
molar volume and nail plate/hoof swelling was found. This was
expected from the literature, where a permeant’s molecular size
has been reported to influence its ungual permeability [11,12].
However, the correlation was small; r = 0.3 for fingernails and for
toenails, and r = 0.5 for hoof samples, i.e. the liquid’s molecular size5 30 35
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regression analysis was performed to evaluate the influence of
molar volume and dD, dP and dH Hansen Solubility Parameters for
each liquid, the dP component was found to be the most important
parameter that influenced nail and hoof swelling (p < 0.05), with
greater swelling in liquids with higher dP. This suggests that polar
drug molecules and polar liquids used as drug carriers are more
likely to permeate into the nail, and that the polarities of drugs
and excipients should be taken into consideration in ungual drug
development.
The greatest changes to the nail/hoof sample were caused by
the acids and bases (p < 0.05), phosphoric acid, lactic acid, ethano-
lamine and ethylene diamine, which even destroyed the hoof
membranes after causing extreme swelling. Acids and bases are
known to damage the nail plate, for example, phosphoric acid
and tartaric acid have been shown to etch and cause significant
changes to the nail plate surface [34,35] while potassium hydrox-
ide is often used to dissolve the nail plate, for example in the
diagnosis of nail fungal infections. As expected, the stronger acid
and base (phosphoric acid, ethylene diamine) caused greater
swelling compared to the weaker acid and base (lactic acid and
ethanolamine) respectively, although for ethylene diamine, the
effect is only obvious for the toenail, possibly due to the large
standard deviations. The greater swelling of the nail plate by
phosphoric acid compared to lactic acid explains the greater nail
plate surface modification and the greater ungual permeation
enhancing effect of phosphoric acid compared to lactic acid
reported by [36].
When the swelling profiles in Figs. 1–3 are examined, it can be
seen that the swelling profiles seem to be liquid-specific, with sim-
ilar profiles obtained for each liquid swelling fingernail, toenail and
hoof. It can also be seen that the swelling profiles are significantly
different for the different liquids. For example, certain liquids such
as water showed a rapid increase in nail mass while other liquids,such as ethylene glycol showed a more gradual change over the
35 days (Figs. 1–3). The different profiles of the liquids over the
35-day experiment reflect the substantially different rates of diffu-
sion of water, propylene glycol and DMSO in the nail reported over
a much shorter timescale of about a day [37]. It can also be seen
from the swelling profiles that the rate of liquid uptake is not con-
stant prior to saturation. Uptake of some liquid seems to cause
changes in the nail plate, for example, opening of the keratin struc-
ture, as suggested by [38], which leads to further solvent uptake,
such that liquid uptake seems to facilitate its own diffusion in
the nail, as discussed in [37].
3.1.3. Nail deswelling
A few liquids caused deswelling of the nail and hoof (Table 1).
No statistical differences in the extent of deswelling were found
amongst these liquids (one way ANOVA, p > 0.05). Deswelling
(corresponding to % mass reduction of 5–15%) occurred mostly
within the first day of sample incubation in a solvent (Figs. 1–
3), and is expected to be due to the extraction of some of the nail
plate water and/or lipid components, which account for 8–22%
and less than 5% of the nail plate mass respectively [29,39,40].
This reflects previous reports of acetone causing a decrease in nail
mass [33] and extracting nail water [32]. Smith et al. also pro-
posed that organic solvents may be used to manipulate nail
hydration [41]. Given the influence of nail water on its properties
such as brittleness [42,43], and its enhancing effect on ungual
drug permeation [44], it may be advisable to avoid those liquids
(shown in Table 1) which deswell the nail in the development
of nail medicines.
Nail swelling has previously been studied as a preformulation/
screening tool [33,45,46] and to understand the effects of organic
solvents on the barrier properties of the nail [41]. Most of the
reported studies have however used aqueous solutions, and uptake
Amorolfine HCl 
Terbinafine HCl 
Ciclopirox olamine 
   efinaconazole 
Fig. 4. Chemical structures of amorolfine HCl, terbinafine HCl, ciclopirox olamine
and efinaconazole.
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extensively studied. This investigation on the behaviour of nails
in a wide range of neat organic liquids shows liquids which: (i)
cause no obvious change to the nail, (ii) deswell the nail and
thereby may be deleterious to nail health and hinder ungual drug
permeation, (iii) permeate into the nail to a great extent and could
thereby drag topically-applied drugs into the nail, and (iv) are
damaging to the nail, but which could act as ungual enhancers if
used in lower concentrations.
3.2. Hansen Solubility Parameters (HSPs) of nail and hoof
Nail and hoof HSPs calculated from swelling measurements are
shown in Table 2. Good fits (0.8–1.0) to the data were obtained
with the HSPiP software, and it can be seen that fairly high dP
and dH values for the nail and hoof were obtained. As a comparison,
the dD, dP and dH of fat (lard) have been reported to be 15.9, 1.1 and
5.4 while those of blood serum have been reported to be 23.2, 22.7
and 30.6 respectively [47]. The high dD, dP and dH values of nail and
hoof are explained by the fact that their primary constituent is the
a-keratin protein. The proportions of the different amino acids
(number of residues per 100) in the nail plate have been found
to be: lysine (3.1%), histidine (1.0%), arginine (6.4%), aspartic acid
(7.0%), threonine (6.1%), serine (11.3%), glutamic acid (13.6%), pro-
line (5.9%), glycine (7.9%), alanine (5.5%), valine (4.2%), methionine
(0.7%), isoleucine (2.7%), leucine (8.3%), tyrosine (3.2%), phenylala-
nine (2.5%), and half cystine (10.6%) while the sulphur content was
3.2% of the nail plates’ dry weight [24]. The amino acid proportions
in bovine hoof are fairly similar, with the proportions (number of
residues per 100) being: lysine (4.3%), histidine (0.8%), arginine
(7.1%), aspartic acid (8.9%), threonine (4.6%), serine (8.3%), glutamic
acid (15.8%), proline (3.2%), glycine (9.4%), alanine (7.2%), valine
(5.8%), methionine (0.5%), isoleucine (3.9%), leucine (10.4%), tyro-
sine (2.9%), phenylalanine (2.6%), and half cystine (4.3%) [48]. The
high dP and dH values of the nail and hoof in Table 2 reflect the nat-
ure of the keratin protein, with its large number of polar amino
acid residues and hydrogen bonds which stabilise the protein.
The high dP and dH values also explain the finding that the nail plate
behaves like a ‘hydrogel’ [49].
The HSPs of the nail and hoof were fairly similar, except for a
slightly lower dP of the hoof (Table 2). The similarities between nail
and hoof HSPs reflect their similar compositions as described
above. It has also been said that the ‘corresponding keratin species
of cow and human are, by and large, highly conserved in their
charge, size and immunoreactivities’ [50]. Mertin and Lippold
showed almost parallel plots for the nail plate and hoof membrane,
when permeability coefficient was plotted against permeant
molecular weight [12], while Murdan et al. showed similar surface
energies of human nail and bovine hoof [51] and Nicoli et al.
showed that human nail and bovine hoof had the same isoelectric
point, which was close to 4 [52]. The similar HSPs between nail and
hoof show that the interaction of a solvent with a nail may be pre-
dicted by its interaction with hoof. Thus, the latter can serve as a
model for the scarce and expensive nail plate in certain experi-
ments. The slightly lower dP of the hoof compared to the nail could
be due to the slight differences in the proportions of the different
amino acids, for example, the nail being richer in the polar
cysteine.
As expected, the values of dD, dP and dH were similar for finger-
nails and toenails (Table 2). While certain differences between fin-
gernails and toenails have been reported, for example, their
dehydration profiles, growth rates, thickness, concentration of cal-
cium and magnesium, surface pH, transonycheal water loss, Raman
spectra and different susceptibilities to fungal infections [30,53–
60], fingernails and toenails are, by and large, almost the same
material, which is shown by their same dD, dP and dH.3.3. HSPs of the terbinafine HCl, amorolfine HCl, ciclopirox olamine
and efinaconazole
The estimated HSPs and chemical structures of the anti-
onychomycotic drugs are shown in Table 3 and Fig. 4 respectively.
The salts terbinafine HCl, amorolfine HCl and ciclopirox olamine
have high polar and hydrogen bonding parameters in contrast to
efinaconazole. Knowledge of the HSPs of these drugs enables one
to understand the potential interactions between the nail and
these drugs. In addition, the known drug HSPs can also be used
in the rational design of these drugs’ formulations [61].3.4. Validation of the HSP measurements
To verify that the experimentally determined HSPs shown in
Tables 2 and 3 may be used for predictions, nail/hoof swelling
and drug solubility in a number of previously unused liquids were
predicted and experimentally tested. The results are shown in
Tables 4 and 5. It can be seen that, of the nine liquids tested for nail
and hoof swelling, agreement between predicted and experimental
swelling was found for seven liquids for fingernails and toenails,
and for eight liquids for the hoof. The predictions were correct
for 82% of the nail/hoof and liquid combinations. Meanwhile, the
Table 5
Predicted and experimentally-determined solubilities of the three drugs in liquids.
Liquid Ciclopirox olamine Amorolfine HCl Terbinafine HCl
Drug/liquid
RED
Solubility predicted;
experimentally-determined
Drug/liquid
RED
Solubility predicted;
experimentally-determined
Drug/liquid
RED
Solubility predicted;
experimentally-determined
Pyrrole 0.5 Yes; yes 0.6 Yes; yes 0.7 Yes; yes
Allyl alcohol 0.4 Yes; yes 0.4 Yes; yes 0.4 Yes; yes
Benzyl butyl phthalate 1.03 No; no 1.2 No; no 1.1 No; no
Dibutyl phthalate 1.04 No; no 1.2 No; no 1.1 No; no
Propylene glycol 0.5 Yes; yes 0.5 Yes; yes 0.6 Yes; yes
Propanol 0.5 Yes; yes 0.7 Yes; yes 0.7 Yes; yes
Piperidine 0.8 Yes; yes 1.0 No; no 1.1 No; no
Table 6
Drug–nail interactions: HSP-based predictions and literature-based confirmation.
HSP-based Literature reports of drug-keratin interaction
Drug Drug–nail RED value for
fingernail; toenail; hoof
Predicted interaction between
drug and nail/hoof
Sugiura et al. [15] Tatsumi et al. [13]
% free druga % drug release
from keratinb
% drug bound
to keratinc
% drug release
from keratind
Amorolfine HCl 0.7; 0.8; 0.5 Yes 1.9 ± 0.2 6.9 ± 0.1 92 39
Terbinafine HCl 0.5; 0.6; 0.5 Yes ND ND 96 22
Ciclopirox olamine 0.6; 0.6; 0.3 Yes 0.7 ± 0.0 2.4 ± 0.2 ND ND
Efinaconazole 1.6; 1.8; 1.7 No 14.3 ± 0.4 46.0 ± 0.6 63 67
ND-not determined.
a % of free drug measured following the incubation of drug with keratin in Tris–HCl buffer at 37 C for 1 h.
b % drug release from drug-loaded keratin after 5 washes.
c % of drug bound to keratin measured following the incubation of drug with keratin in saline at 37 C for 1 h.
d % drug release from drug-loaded keratin after 10 washes.
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relations between prediction and experimental finding confirm
that the HSPs shown in Tables 2 and 3 can be used as a guide to
select liquids for use in, for example, nail cosmetics and drug for-
mulation, based on the liquids’ HSPs. The latter are available for
a very large number of liquids, for example, in the HSPiP software
and in [27]. The less than 100% correlation between the predicted
and experimentally-determined swelling of nail/hoof is not unex-
pected. During HSP determination, a few solvents are sometimes
incorrectly placed outside or inside of the HSP sphere, when the
latter is being fitted; hence, the fit is less than 1.0.
3.5. Prediction of drug–nail interactions using HSPs
Calculated drug–nail RED values and related predictions of
drug–nail affinities are shown in Table 6, along with literature-
based values of keratin-drug interactions. Amorolfine HCl, terbi-
nafine HCl and ciclopirox olamine are predicted to have high
affinities for the nail and hoof (as their nail–drug RED values
are less than 1), while efinaconazole is predicted to have low
affinity (nail–drug RED being higher than 1). These predictions
perfectly match literature reports of these drugs’ interactions
with keratin, as shown in Table 6. When amorolfine HCl, terbina-
fine HCl and ciclopirox olamine were incubated with keratin
powder, most of the drug became bound to the keratin, and sub-
sequent washing of the drug-loaded keratin resulted in low levels
of drug release [13,15]. In contrast, a much smaller proportion of
efinaconazole became bound to keratin, and subsequent washing
of the drug-loaded keratin resulted in greater levels of drug
release.
It can also be seen from Table 6 that drug–nail/hoof RED
values (Table 6) for fingernail, toenail and hoof are fairly simi-
lar, being either above 1 (for efinaconazole) or below 1 (for the
other three drugs). This is due to their HSPs being similar (as
shown in Table 2) and indicates that hoof pieces may be usedas a model for the nail plate when drug–nail interactions are
being investigated.
4. Conclusions
We report the swelling behaviour of nails in a wide range of
organic liquids. A number of organic liquids cause no obvious
change to the nail plate, others deswell the nail and may thereby
adversely influence its health and its permeability, others swell
and could drag permeant into the nail plate, while others are dam-
aging to the nail but could possibly be used as ungual enhancers at
low concentrations. The nail plate and hoof showed similar HSPs
and high polar and hydrogen-bonding parameters, reflecting their
principal constituent of keratin. As expected fingernail and toenail
HSPs were almost the same, while hoof HSPs were similar to nail
HSPs, indicating their usefulness as models for the nail plate. The
HSPs of the anti-onychomycotic drugs terbinafine HCl, amorolfine
HCl and ciclopirox olamine were also experimentally determined,
while that of efinaconazole was calculated using the HSPiP
software.
We showed that nail and drug HSP values can be used to predict
the nail swelling and drug solubility respectively, in liquids whose
Hansen Solubility Parameters are known. Furthermore, we showed
that HSPs can be used to predict drug–nail affinities. High affinities
between the nail/hoof and amorolfine HCl, terbinafine HCl and
ciclopirox olamine and low efinaconazole-nail affinity were pre-
dicted, and these predictions were found to accurately match
experimentally-determined literature reports of the binding char-
acteristics of these drugs to keratin. Predicted drug–nail and
drug-hoof interactions were the same, indicating the applicability
of the hoof as a model for the nail plate in such experiments.
Finally, we propose that the reported values of nail HSPs may be
used to predict the nail’s interactions with other drugs, which
could assist the design of new drugs for the treatment of nail dis-
eases, such as onychomycosis and psoriasis.
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